Simco-Ion Introduces the Eltex TERRALIGHT Ground Monitoring System: Elevating Safety and Efficiency in Industrial Settings
HATFIELD, Pa., Sept. 3, 2024 /PRNewswire/ — Simco-Ion, a leader in industrial static control solutions, is excited to announce the release of the Eltex TERRALIGHT... Read more.
Outskirt Films Unveils Cinematic Website Redesign with Tegan Digital
DALLAS, Sept. 3, 2024 /PRNewswire/ — Outskirt Films, a visionary filmmaking studio renowned for its interview-driven storytelling and captivating short documentaries,... Read more.
DiscoverGreece.com Launches Europe’s First Custom Version of GuideGeek Travel AI
ATHENS, Greece, Sept. 3, 2024 /PRNewswire/ — Travelers planning a trip to Greece or traveling in the country now have a free AI travel assistant called Pythia... Read more.
Leadership Expert Releases Strategies for Thriving in a Turbulent World
CLEARWATER, Fla., Sept. 3, 2024 /PRNewswire/ — Rob Faw, a distinguished leadership expert with over 40 years of global experience, has launched his latest... Read more.
Emeren Appoints Dr. Ramki Srinivasan to Its Board of Directors
STAMFORD, Conn., Sept. 3, 2024 /PRNewswire/ — Emeren Group Ltd (“Emeren” or the “Company”) (www.emeren.com) (NYSE: SOL), a leading... Read more.
Vivacelle Bio Enrolls First Patient in Phase 3 Trial of Hypovolemia Due to Septic Shock for Phospholipid Nanoparticle-Based VBI-S
Septic shock results in approximately 350,000 deaths in the U.S. each year, the leading cause of hospital-related mortality and a major financial burden for the... Read more.
Haivision MCS Awarded $61.2 Million Production Agreement by US Navy for Next-Generation Combat Visualization and Video Distribution Systems
MONTREAL, Sept. 3, 2024 /PRNewswire/ – Haivision Systems Inc. (“Haivision”) (TSX: HAI), a leading global provider of mission-critical, real-time... Read more.
PhaseV to Present at Upcoming Healthcare, Pharma and Technology Events
New Research and Case Studies Demonstrate Effectiveness of Machine Learning-Based Platforms for Adaptive Clinical Trial Design and Analysis BOSTON, Sept. 3, 2024... Read more.
PTC Appoints Rob Bernshteyn to Board of Directors
BOSTON, Sept. 3, 2024 /PRNewswire/ — PTC (NASDAQ: PTC) today announced that it has appointed Rob Bernshteyn to its Board of Directors, effective September... Read more.
Albatroz Therapeutics Soars into Johnson & Johnson Innovation – JLABS Singapore
SINGAPORE, Sept. 3, 2024 /PRNewswire/ — Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today... Read more.